NEUROLOGY PROCEDURES

NEUROLOGY PROCEDURES

CAT neuro01

CISTERNOGRAPHY

DESCRIPTION

Evaluation of the dynamics of the cerebrospinal fluid (CSF).

PREPARATION

  • No previous preparation is necessary.
  • No fasting is required.

INDICATIONS

  • Diagnosis of normotensive hydrocephalus.
  • Identification of liquorrheae or cerebrospinal fluid fistulae (CSF).
  • Determination of the permeability of surgical derivations.

DURATION OF
PROCEDURE

48 hours.

CISTERNOGRAPHY

DESCRIPTION

Evaluation of the dynamics of the cerebrospinal fluid (CSF).

PREPARATION

  • No previous preparation is necessary.
  • No fasting is required.

INDICATIONS

  • Diagnòstic d’hidrocefàlia normotensiva.

  • Identificació de licuorrees o fístules de líquid cefaloraquidi (LCR).

  • Permeabilitat de les derivacions quirúrgiques.

DURATION OF PROCEDURE

48 hours.

CAT neuro02

18F-FDG NEUROLOGIC PET-CT

DESCRIPTION

Study of glucose metabolism of the brain.

PREPARATION

  • Four to six-hour fasting.
  • The patients should take the usual medication. There is the possibility of withdrawing the psychotropic drugs.
  • Diabetic patients should take their usual medication.
  • If needed, a sedation will be performed 20 minutes after the administration of FDG, preferably before images acquisition, according to the anesthesia procedure.

INDICATIONS

  • Early diagnosis and differential diagnosis of dementias.
  • Study of movement disorders, for the characterization of atypical parkinsonisms.
  • Delimitation of the epileptographic focus of interictal phase in epilepsy.
  • Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
  • Evaluation of cranioencephalic traumatisms and cerebrovascular pathologies.

DURATION OF
PROCEDURE

30 minutes.

18F-FDG NEUROLOGIC PET-CT

DESCRIPTION

Study of glucose metabolism of the brain.

PREPARATION

  • Four to six-hour fasting.
  • The patients should take the usual medication. There is the possibility of withdrawing the psychotropic drugs.
  • Diabetic patients should take their usual medication.
  • If needed, a sedation will be performed 20 minutes after the administration of FDG, preferably before images acquisition, according to the anesthesia procedure.

INDICATIONS

  • Early diagnosis and differential diagnosis of dementias.
  • Study of movement disorders, for the characterization of atypical parkinsonisms.
  • Delimitation of the epileptographic focus of interictal phase in epilepsy.
  • Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
  • Evaluation of cranioencephalic traumatisms and cerebrovascular pathologies.

DURATION OF PROCEDURE

30 minutes.

CAT neuro03

BRAIN TOMOSCINTIGRAPHY (SPET/SPET-TC) WITH
TUMORAL AFFINITY OR METABOLIC ACTIVITY RADIOTRACERS

DESCRIPTION

Evaluation of the encephalic uptake of thallium or technetium compounds by tumors.

PREPARATION

No previous preparation is necessary.

INDICATIONS

  • Evaluation of the degree of malignancy and metabolic activity of brain tumors.
  • Evaluation of the therapeutic response of brain tumors to surgery or radiotherapy and detection of recurrences, allowing differentiation of radionecrosis.
  • Differential diagnosis between lymphoma and other brain masses (toxoplasmosis …) in HIV-positive patients.

DURATION OF
PROCEDURE

2 to 24 hours.

BRAIN TOMOSCINTIGRAPHY (SPET/SPET-TC)
WITH TUMORAL AFFINITY OR METABOLIC
ACTIVITY RADIOTRACERS

DESCRIPTION

Evaluation of the encephalic uptake of thallium or technetium compounds by tumors.

PREPARATION

No previous preparation is necessary.

INDICATIONS

  • Evaluation of the degree of malignancy and metabolic activity of brain tumors.
  • Evaluation of the therapeutic response of brain tumors to surgery or radiotherapy and detection of recurrences, allowing differentiation of radionecrosis.
  • Differential diagnosis between lymphoma and other brain masses (toxoplasmosis …) in HIV-positive patients.

DURATION OF PROCEDURE

2 to 24 hours.

CAT neuro04

BRAIN ANGIOSCINTIGRAPHY

BRAIN SCINTIGRAPHY FOR ENCEPHALIC DEATH

PREFUSION BRAIN TOMOGRAPHY (SPET)

POST-PHARMACOLOGICAL INTERVENTION
PERFUSION BRAIN TOMOGRAPHY (SPET)

POST-NEUROACTIVATION PERFUSION BRAIN TOMOGRAPHY (SPET)

DESCRIPTION

Evaluation of cerebral perfusion and brain metabolic activity through the administration of a perfusion/neuronal metabolism radiotracer.

PREPARATION

  • No special preparation is required.
  • It is recommended to avoid the use of drugs acting on the central nervous system.

INDICATIONS

  • Evaluation of cerebral perfusion.
  • Diagnosis of thromboembolic or infarct disease.
  • Diagnosis of brain death.
  • By tomographic studies:

    • Differential diagnosis of dementias (Alzheimer’s, Pick, multi-infarction).
    • Pre-surgical evaluation of the epileptic patient: location of the epileptographic focus on complex partial crises and assessment of cerebral perfusion during the amobarbital test.
    • Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
    • Determination of cerebral vascular pathologies.
    • Determination of Chronic Fatigue Syndrome.
    • Evaluation of cranioencefacial traumatisms.
    • Evaluation of clinical-radiological dissociation.
    • Diagnosis of systemic diseases (LES, Behçet, etc.).

DURATION OF
PROCEDURE

40 minutes.

BRAIN ANGIOSCINTIGRAPHY

BRAIN SCINTIGRAPHY FOR ENCEPHALIC DEATH

PREFUSION BRAIN TOMOGRAPHY (SPET)

POST-PHARMACOLOGICAL INTERVENTION
PERFUSION BRAIN TOMOGRAPHY (SPET)

POST-NEUROACTIVATION
PERFUSION BRAIN TOMOGRAPHY (SPET)

DESCRIPTION

Evaluation of cerebral perfusion and brain metabolic activity through the administration of a perfusion/neuronal metabolism radiotracer.

PREPARATION

  • No special preparation is required.
  • It is recommended to avoid the use of drugs acting on the central nervous system.

INDICATIONS

  • Evaluation of cerebral perfusion.
  • Diagnosis of thromboembolic or infarct disease.
  • Diagnosis of brain death.
  • By tomographic studies:

    • Differential diagnosis of dementias (Alzheimer’s, Pick, multi-infarction).
    • Pre-surgical evaluation of the epileptic patient: location of the epileptographic focus on complex partial crises and assessment of cerebral perfusion during the amobarbital test.
    • Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
    • Determination of cerebral vascular pathologies.
    • Determination of Chronic Fatigue Syndrome.
    • Evaluation of cranioencefacial traumatisms.
    • Evaluation of clinical-radiological dissociation.
    • Diagnosis of systemic diseases (LES, Behçet, etc.).

DURATION OF PROCEDURE

40 minutes.

CAT neuro05

DATSCAN BRAIN TOMOSCINTIGRAPHY

DOPAMINE (123I-IOFLUPANE) TRANSPORTERS BRAIN TOMOSCINTIGRAPHY (SPECT)

DESCRIPTION

  • Evaluation of the capture of ioflupane in the presynaptic dopaminergic receptors of the basal ganglia.
  • Presynaptic study of the nigrostriatal way.

PREPARATION

  • No previous preparation required.
  • Twenty drops of lugol (iodine) solution are administered 45-60 minutes before the procedure.

INDICATIONS

Differential diagnosis of Parkinson’s disease and Parkinsonian syndromes.

DURATION OF
PROCEDURE

4 hours.

DATSCAN BRAIN TOMOSCINTIGRAPHY

DOPAMINE (123I-IOFLUPANE) TRANSPORTERS
BRAIN TOMOSCINTIGRAPHY (SPECT)

DESCRIPTION

  • Evaluation of the capture of ioflupane in the presynaptic dopaminergic receptors of the basal ganglia.
  • Presynaptic study of the nigrostriatal way.

PREPARATION

  • No previous preparation required.
  • Twenty drops of lugol (iodine) solution are administered 45-60 minutes before the procedure.
  •  

INDICATIONS

Differential diagnosis of Parkinson’s disease and Parkinsonian syndromes.

DURATION OF PROCEDURE

4 hours.

CAT neuro06

PET-CT FOR THE DETECTION OF AMYLOID PLAQUE

DESCRIPTION

Evaluation of presence of β-Amyloid in the brain.

PREPARATION

No previous preparation needed.

INDICATIONS

Early diagnosis and differential diagnosis of dementias by determining the presence or absence of β-Amyloid.

DURATION OF
PROCEDURE

2 to 24 hours.

PET-CT FOR THE DETECTION OF AMYLOID PLAQUE

DESCRIPTION

Evaluation of presence of β-Amyloid in the brain.

PREPARATION

No previous preparation needed.

INDICATIONS

Early diagnosis and differential diagnosis of dementias by determining the presence or absence of β-Amyloid.

DURATION OF PROCEDURE

2 to 24 hours.

Logo-SIMM-Largo

Josep Irla & Bosch Street, 5-7, Basement, Barcelona 08034, Catalonia, Spain
(+34) 93 204 6439, (+34) 93 205 7708 Fax (+34) 93 204 8641 info@simm.barcelona

LogosCalidadJuntos
Logo-SIMM-Largo

Josep Irla & Bosch Street, 5-7, Basement, Barcelona 08034, Catalonia, Spain
Phones (+34) 93 204 6439 & (+34) 93 205 7708 Fax (+34) 93 204 8641
E-mail info@simm.barcelona

LogosCalidadJuntos